Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CYCLOSPORINE | 0.05% | EMULSION | Actual shortage | 2024-05-16 | 2024-05-30 | 228149 |
TEVA-ROPINIROLE | 5MG | TABLET | Resolved | 2021-04-01 | 2024-05-30 | 136751 |
TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-02-09 | 2024-05-30 | 184216 |
TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2024-02-01 | 2024-05-30 | 218132 |
TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2023-06-19 | 2024-05-30 | 195456 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2024-03-18 | 2024-05-30 | 222569 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2024-05-09 | 2024-05-30 | 227489 |
TEVA-NITROFURANTOIN | 100MG | CAPSULE | Resolved | 2024-02-15 | 2024-05-30 | 219677 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2024-03-07 | 2024-05-30 | 221540 |
TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2024-02-01 | 2024-05-30 | 218137 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2024-03-28 | 2024-05-30 | 223850 |
TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2023-06-19 | 2024-05-30 | 195481 |
TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2021-12-17 | 2024-05-30 | 151465 |
TEVA-LACOSAMIDE | 50MG | TABLET | Resolved | 2024-03-18 | 2024-05-30 | 222575 |
TEVA-CLOBAZAM | 10MG | TABLET | Actual shortage | 2024-05-30 | 2024-05-30 | 229230 |
TEVA-NAPROXEN | 500MG | TABLET | Actual shortage | 2024-05-16 | 2024-06-07 | 228140 |
TEVA-ECTOSONE | 0.05% | LOTION | Actual shortage | 2024-03-28 | 2024-06-07 | 223832 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Actual shortage | 2024-05-30 | 2024-06-07 | 229233 |
TEVA-DOXYCYCLINE | 100MG | TABLET | Actual shortage | 2024-04-18 | 2024-06-07 | 225483 |
TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2023-10-19 | 2024-06-07 | 207512 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATENOLOL | 50MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106142 |
TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |
ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
TEVA-ARIPIPRAZOLE | 2MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115085 |
CEFOXITIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2020-05-14 | 2020-05-14 | 115088 |
TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |
ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |